Egalet Corporation
Founded 1995
Wayne, United States
11 employees
Post Ipo Debt
Total: $115.20M
Biopharma, Biotechnology +1
Wayne, United States
11 employees
Post Ipo Debt
Total: $115.20M
Biopharma, Biotechnology +1
General Information
Get notified when Egalet Corporation moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Egalet Corporation
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biopharma
About Egalet Corporation
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | •••••• | - | 01 Sep 2016 | |
| Post-IPO Equity | •••••• | 4 |
|
11 Feb 2014 |
| Venture Round | •••••• | 1 |
|
17 Sep 2013 |
| Series B | •••••• | 5 |
|
07 May 2012 |
| Series B | •••••• | - | 02 Apr 2007 |
FAQ About Egalet Corporation
Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products: ARYMO™ ER (morphine sulfate) extended-release tablets for oral use only –CII, developed us...
Egalet Corporation was founded in 1995.
Egalet Corporation is headquartered in Wayne, United States.
Egalet Corporation operates in the following industries: Biopharma, Biotechnology, Health Care.
Egalet Corporation has approximately 11 employees.
Egalet Corporation has completed 6 funding rounds, raising a total of $115.20M. The latest funding stage is Post Ipo Debt.
We're actively collecting intelligence on Egalet Corporation.
Track Egalet Corporation to get notifiedDon't just browse. Track.
Signal Tracker monitors Egalet Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
